189 related articles for article (PubMed ID: 36170817)
1. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I
Chimienti R; Baccega T; Torchio S; Manenti F; Pellegrini S; Cospito A; Amabile A; Lombardo MT; Monti P; Sordi V; Lombardo A; Malnati M; Piemonti L
Cell Rep; 2022 Sep; 40(13):111423. PubMed ID: 36170817
[TBL] [Abstract][Full Text] [Related]
2. iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors.
Bogomiakova ME; Sekretova EK; Anufrieva KS; Khabarova PO; Kazakova AN; Bobrovsky PA; Grigoryeva TV; Eremeev AV; Lebedeva OS; Bogomazova AN; Lagarkova MA
Stem Cell Res Ther; 2023 Apr; 14(1):77. PubMed ID: 37038186
[TBL] [Abstract][Full Text] [Related]
3. Generation of Monkey Induced Pluripotent Stem Cell-Derived Cartilage Lacking Major Histocompatibility Complex Class I Molecules on the Cell Surface.
Okutani Y; Abe K; Yamashita A; Morioka M; Matsuda S; Tsumaki N
Tissue Eng Part A; 2022 Jan; 28(1-2):94-106. PubMed ID: 34182799
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts.
Phillips LK; Gould EA; Babu H; Krams SM; Palmer TD; Martinez OM
Stem Cells; 2013 Sep; 31(9):1829-39. PubMed ID: 23733329
[TBL] [Abstract][Full Text] [Related]
5. Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.
Glasner A; Oiknine-Djian E; Weisblum Y; Diab M; Panet A; Wolf DG; Mandelboim O
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878071
[TBL] [Abstract][Full Text] [Related]
6. Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes.
Frenzel LP; Abdullah Z; Kriegeskorte AK; Dieterich R; Lange N; Busch DH; Krönke M; Utermöhlen O; Hescheler J; Sarić T
Stem Cells; 2009 Feb; 27(2):307-16. PubMed ID: 18988711
[TBL] [Abstract][Full Text] [Related]
7. Immunological Properties of Murine Parthenogenetic Stem Cells and Their Differentiation Products.
Johannsen H; Muppala V; Gröschel C; Monecke S; Elsner L; Didié M; Zimmermann WH; Dressel R
Front Immunol; 2017; 8():924. PubMed ID: 28824647
[TBL] [Abstract][Full Text] [Related]
8. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC
J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224
[TBL] [Abstract][Full Text] [Related]
9. Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition.
Alari-Pahissa E; Grandclément C; Jeevan-Raj B; Leclercq G; Veillette A; Held W
PLoS One; 2016; 11(4):e0153236. PubMed ID: 27054584
[TBL] [Abstract][Full Text] [Related]
10. Contribution of inhibitory receptor TIGIT to NK cell education.
He Y; Peng H; Sun R; Wei H; Ljunggren HG; Yokoyama WM; Tian Z
J Autoimmun; 2017 Jul; 81():1-12. PubMed ID: 28438433
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
Ma D; Niederkorn JY
Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
[TBL] [Abstract][Full Text] [Related]
12. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.
Flahou C; Morishima T; Takizawa H; Sugimoto N
Front Immunol; 2021; 12():662360. PubMed ID: 33897711
[TBL] [Abstract][Full Text] [Related]
13. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
14. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility.
Xu H; Wang B; Ono M; Kagita A; Fujii K; Sasakawa N; Ueda T; Gee P; Nishikawa M; Nomura M; Kitaoka F; Takahashi T; Okita K; Yoshida Y; Kaneko S; Hotta A
Cell Stem Cell; 2019 Apr; 24(4):566-578.e7. PubMed ID: 30853558
[TBL] [Abstract][Full Text] [Related]
15. MHC-matched induced pluripotent stem cells can attenuate cellular and humoral immune responses but are still susceptible to innate immunity in pigs.
Mizukami Y; Abe T; Shibata H; Makimura Y; Fujishiro SH; Yanase K; Hishikawa S; Kobayashi E; Hanazono Y
PLoS One; 2014; 9(6):e98319. PubMed ID: 24927426
[TBL] [Abstract][Full Text] [Related]
16. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
17. The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses.
Rahim MM; Chen P; Mottashed AN; Mahmoud AB; Thomas MJ; Zhu Q; Brooks CG; Kartsogiannis V; Gillespie MT; Carlyle JR; Makrigiannis AP
Blood; 2015 Apr; 125(14):2217-27. PubMed ID: 25612621
[TBL] [Abstract][Full Text] [Related]
18. The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors.
Železnjak J; Lisnić VJ; Popović B; Lisnić B; Babić M; Halenius A; L'Hernault A; Roviš TL; Hengel H; Erhard F; Redwood AJ; Vidal SM; Dölken L; Krmpotić A; Jonjić S
J Exp Med; 2019 Aug; 216(8):1809-1827. PubMed ID: 31142589
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome Analysis of Induced Pluripotent Stem Cell (iPSC)-derived Pancreatic β-like Cell Differentiation.
Huang Y; Wan J; Guo Y; Zhu S; Wang Y; Wang L; Guo Q; Lu Y; Wang Z
Cell Transplant; 2017 Aug; 26(8):1380-1391. PubMed ID: 28901190
[TBL] [Abstract][Full Text] [Related]
20. A dual function of NKG2D ligands in NK-cell activation.
Cheney EE; Wise EL; Bui JD; Schreiber RD; Carayannopoulos LN; Spitzer D; Zafirova B; Polic B; Shaw AS; Markiewicz MA
Eur J Immunol; 2012 Sep; 42(9):2452-8. PubMed ID: 22740149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
